SVP Lynette Holzbaur’s $346k Insider Buy Fuels Optimism Ahead of Sun Pharma’s $12B Takeover of Organon & Co.
Insider buying surge signals confidence ahead of Sun Pharma’s $12bn takeover of Organon, boosting share value and future upside.
3 minutes to read